24 April 2018
Seven new pharmaceutical enterprises will be established in Neudorf and Novoorlovskaya sites of St. Petersburg Special Economic Zone (SEZ) by the end of 2018.
This was announced by Dmitry Panov, acting Chairman of the Regional Association of Delovaya Rossiya, member of the staff office under the Governor of St. Petersburg for improving business performance, at the discussion club “Free Zone Battle: Best International Practices in the Management of Special Economic Zones” during the Yalta International Economic Forum (YIEF).
“St. Petersburg is the pharmaceutical capital of Russia, most pharmaceutical companies made perfect arrangements in Neudorf and Novoorlovskaya sites of St. Petersburg Special Economic Zones. Today, there are about 46 companies. In 2017, this generated for the city the revenues of more than 2.6 billion rubles. In 2018, we expect the opening of another seven production facilities there. In particular, this will include NPO Burevestnik, a division of ALROSA Group,” said Mr. Panov.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Health Ministry has added two new conditions to the list of rare diseases
14 May 2024
Novel preservation method could improve storage of biologics
14 May 2024
mRNA cancer vaccine granted world-first approval
13 May 2024
Life expectancy of Russians citizens should reach 81 years by 2036
13 May 2024